Anticancer effects of licochalcones: A review of the mechanisms
Frontiers in Pharmacology · 23.01.2023 · 14
DOI: 10.3389/fphar.2023.1074506 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 23.01.2023. Verfasst von Nan Deng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer is a disease with a high fatality rate representing a serious threat to human health. Researchers have tried to identify effective anticancer drugs. Licorice is a widely used traditional Chinese medicine with various pharmacological properties, and licorice-derived flavonoids include licochalcones like licochalcone A, licochalcone B, licochalcone C, licochalcone D, licochalcone E, and licochalcone H. By regulating the expression in multiple signaling pathways such as the EGFR/ERK, PI3K/Akt/mTOR, p38/JNK, JAK2/STAT3, MEK/ERK, Wnt/β-catenin, and MKK4/JNK pathways, and their downstream proteins, licochalcones can activate the mitochondrial apoptosis pathway and death receptor pathway, promote autophagy-related protein expression, inhibit the expression of cell cycle proteins and angiogenesis factors, regulate autophagy and apoptosis, and inhibit the proliferation, migration, and invasion of cancer cells. Among the licochalcones, the largest number of studies examined licochalcone A, far more than other licochalcones. Licochalcone A not only has prominent anticancer effects but also can be used to inhibit the efflux of antineoplastic drugs from cancer cells. Moreover, derivatives of licochalcone A exhibit strong antitumor effects. Currently, most results of the anticancer effects of licochalcones are derived from cell experiments. Thus, more clinical studies are needed to confirm the antineoplastic effects of licochalcones.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
- Chongqing Institute for Food and Drug Control, Chongqing, China.
Zitieren
APA
Deng, N., Qiao, M., Li, Y., Liang, F., Li, J., & Liu, Y. (2023). Anticancer effects of licochalcones: A review of the mechanisms. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1074506
Vancouver
Deng N, Qiao M, Li Y, Liang F, Li J, Liu Y. Anticancer effects of licochalcones: A review of the mechanisms. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1074506
BibTeX
@article{Deng2023,
author = {Deng, Nan and Qiao, Mingming and Li, Ying and Liang, Fengyan and Li, Jingjing and Liu, Yanfeng},
title = {Anticancer effects of licochalcones: A review of the mechanisms},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1074506}
}
EUVIMED